Effect of Palpatory Neuromodulation of the Trigeminal Nerve for Tenderness in the Posterior Neck Musculature

NCT ID: NCT04936659

Last Updated: 2021-06-25

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 78 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2017-10-13
• Study Completion Date: 2020-05-01

Brief Summary

The purpose of this study is to assess the extent to which a non-invasive, palpatory neuromodulatory protocol on the trigeminal nerve endings on the face can affect tenderness felt on the posterior neck musculature, using the Isotouch pressure sensor system.

Specific Aim 1: Subjects will see a decrease in tenderness in the posterior neck musculature.

Specific Aim 2: Subjects will show a decrease in tenderness on the trigeminal tender points found on the face.

Detailed Description

Study Instrumentation: The Isotouch sensor device and software is a passive sensor device that allows for real-time, constant visualization of pressure information. The system electronics are remote (on the packet usually worn on the wrist) and the current supports a Bluetooth data stream. The sensor has input power on the wrist and minimal microcurrent output. The pressure range for the device ranges from 0-100 pounds per square inch (PSI), although this study will only be using pressure of 0.5 to three pounds of pressure. The sensors are made of both cloth and Polyimide material. This software will be directly used in the neuromodulatory intervention as described below. The sensors will be used both for the palpatory evaluation of trigeminal tender points on the face as well as the neuromodulation portion of the protocol.

Subjects interested in the study will email the NeckPainResearch@unthsc.edu account to express their interest in participating. The co-investigators will email the subject an initial survey to answer questions about the inclusion and exclusion criteria. This survey will primarily consist of questions related to the potential participant's medical history, to best determine if they qualify for the study. If subjects qualify, they will be contacted via telephone (by the principal or a co-investigator) to schedule a time to participate in the study visit. Once a visit is scheduled, the participant will meet the investigators in a private setting either at the UNTHSC campus or other community based designated area. After the consenting process is completed, the inclusion and exclusion criteria will be re-reviewed. If the subject qualifies, they will be consented and fill out a brief questionnaire. Subjects will be verbally asked for demographic information including their age, weight, height, gender, and have their neck circumference measured by the principal investigator or a co-investigator.

After consenting, the subject will be taken to the operator (the principal or co-investigator) who will be in clinical patient room with the IsoTouch software (see diagram). The subject will lie supine on the exam table.

The operator will be wearing two IsoTouch finger sensors; one on each index finger. Non-latex coverings will be used over the IsoTouch software pressure sensors to protect the instrumentation from the natural oils of human skin, as well as the participant. The operator will palpate 1 inch posteromedial from the posterior aspect of the mastoid process (posterior neck) on each side with 3 pounds of pressure to determine if any tenderness is present, and the subject will verbally give a pain rating between 0-10. This will be referred to as the left and right cervical sites of tenderness (CSOT).

Next, using the IsoTouch finger sensor, the trigeminal nerve endings will be palpated for tenderness with 2 lbs of pressure and subjects will verbally give a pain rating on a scale of 0-10 at the following sites: V1, and V2 branches of the trigeminal nerve on the face which will be referred to as trigeminal tender points (TTPs, see below diagram). The three most tender TTPs will be documented.

Two lbs of pressure will be used on the facial sites as the anatomy is significantly different. The facial structures in general are much more superficial than the layers of musculature in the posterior neck. Therefore, the pressure will be less on the face than it is on the posterior neck musculature.

The operator will keep one monitoring sensor with minimal pressure (less than 0.5 lbs of pressure) at the CSOT while the other sensor/sensing hand applies steady pressure to each of the TTPs. The CSOT remains the same throughout the protocol and does not change sides, as it will be reevaluated when the protocol is completed.

The three most tender TTPs will be palpated with steady pressure (two lbs of pressure) for 30 seconds, as this step is the neuromodulation intervention. In the event that there are two tender points rated the same (and not zero), the investigators will repeat assessment of each trigeminal area again to be rated by the subject. If it happens that the same values are again recorded, the investigators will include both tender points in our protocol, potentially including four TTPs in the intervention. Any anomalies will be noted in the data collection. The steady pressure is continuously recorded via the pressure sensing IsoTouch pads and monitored in real time by the operator to keep it consistent with each intervention. After the TTP's have the intervention, their face will not be touched again.

After all three of the TTPs assessed to have tenderness have received the intervention, the CSOT will be rechecked with the same initial pressure (3lbs) to evaluate pain changes.

For Example, The CSOT on the right was assessed to have an 8/10 tenderness to palpation. V1R, V2R, V2L were found to have the most tenderness. In sequential order, V1R, V2R, V2L will have the neuromodulatory pulsations applied to them, and when complete, the right sided CSOT will be rechecked.

Due to the force signal drift of the ISOTOUCH, and the real-time nature of the software, the pressure/force will be monitored and adjusted accordingly to maintain the appropriate pressure/force throughout the intervention.

This neuromodulatory protocol is finished when the TTPs that were assessed to have the most tenderness each had the 30 second intervention.

The protocol will be ended immediately if any subject asks to stop, or if any significant pain or side effects develop.

Conditions

Neuromodulation; Neck Pain

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Treatment group

Group Type: EXPERIMENTAL

neuromodulation

Intervention Type: OTHER

Palpatory neuromodulation of the V1 and V2 branches of the trigeminal nerve where they exit onto the face.

Interventions

neuromodulation

Palpatory neuromodulation of the V1 and V2 branches of the trigeminal nerve where they exit onto the face.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• . Aged 18-65 2. Has posterior neck muscle discomfort 3. Has none of the following within the past 12 months:

• traumatic brain injury
• concussion
• whiplash
• dental work (cavity filling, root canal, tooth extraction, tooth implantation)
• facial trauma
• facial reconstruction surgery
• diagnosis of migraine headaches with daily or weekly medication use
• diagnosis of cluster type headaches with daily or weekly medication use 4. No neurological diagnoses, such as:

• trigeminal neuralgia
• facial numbness
• paralysis of the face 5. No cervical spine issues such as:
• Bulging disc
• Vertebral fusion surgery
• Vertebral disc removal surgery 6. No skin disorder of the face, neck or scalp such as:
• Shingles/Herpes Zoster 7. Subject is able to lay supine for 15 minutes 8. Not pregnant

Exclusion Criteria

• 1. Below the age of 18 or over the age of 65 2. Any of the following within the past 12 months:

• traumatic brain injury
• concussion
• whiplash
• dental work (cavity filling, root canal, tooth extraction, tooth implantation)
• facial trauma
• facial reconstruction surgery.
• Diagnosis of migraine headaches with daily or weekly medication use
• Diagnosis of cluster headaches with daily or weekly medication use 3. Any of the following neurologic diagnoses:

1. trigeminal neuralgia

2. facial numbness

3. paralysis of the face

4. Cervical spine issues (bulging disc, vertebral fusion, or vertebral disc removal)

5. Skin disorders of the face, neck, or scalp such as Shingles or Herpes Zoster

6. Pregnancy

7. Unable to lay on back for 15 minutes

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

American Osteopathic Association

OTHER

Sponsor Role: collaborator

University of North Texas Health Science Center

OTHER

Sponsor Role: lead

Responsible Party

Kendi Hensel

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Kendi Hensel, DO, PhD

Role: PRINCIPAL_INVESTIGATOR

University of North Texas Health Science Center

Locations

University of North Texas Health Science Center

Fort Worth, Texas, United States

Countries

United States

Other Identifiers

1444471

Identifier Type: -

Identifier Source: org_study_id